Skip to main content
Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
33.12
+0.01 (0.03%)
At close: Apr 28, 2026, 4:00 PM EDT
32.98
-0.14 (-0.42%)
Pre-market: Apr 29, 2026, 5:04 AM EDT

Nanobiotix Revenue

In the year 2025, Nanobiotix had annual revenue of 32.59M EUR, down -553.25%. Nanobiotix had revenue of 5.96M in the half year ending December 31, 2025, a decrease of -81.91%.

Revenue (ttm)
32.59M EUR
Revenue Growth
-553.25%
P/S Ratio
42.05
Revenue / Employee
316,437 EUR
Employees
103
Market Cap
1.61B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202532.59M39.78M-553.25%
Dec 31, 2024-7.19M-43.40M-119.86%
Dec 31, 202336.21M31.43M658.10%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M322.00K13.85%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Monte Rosa Therapeutics 123.67M
Nurix Therapeutics 71.78M
Intellia Therapeutics 67.67M
Nuvation Bio 62.90M
Immatics 56.67M
Generate Biomedicines 31.89M
AtaiBeckley 4.09M
Oculis Holding AG 1.51M
Revenue Rankings

NBTX News

More News